Get the Stockscreener App
10.25
0.28%
0.5699
After Hours:
10.30
0.0499
+0.49%
Daxor Corporation stock is traded at $10.25, with a volume of 7,422.
It is up +0.28% in the last 24 hours and up +5.85% over the past month.
Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
See More
Previous Close:
$10.82
Open:
$11
24h Volume:
7,422
Relative Volume:
0.68
Market Cap:
$61.51M
Revenue:
$503.40K
Net Income/Loss:
$9.17M
P/E Ratio:
5.6602
EPS:
1.8109
Net Cash Flow:
$-604.40K
1W Performance:
-4.49%
1M Performance:
+5.85%
6M Performance:
-17.18%
1Y Performance:
+40.18%
1-Day Range:
$10.25
$11.00
1-Week Range:
$10.20
$11.74
52-Week Range:
$7.73
$14.76
Daxor Corporation Stock (DXR) Company Profile
Name
Daxor Corporation
Sector
Industry
Phone
212-330-8500
Address
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
10.55 | 63.05M | 503.40K | 9.17M | -604.40K | 1.8109 |
ISRG
Intuitive Surgical Inc
|
436.65 | 155.16B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.75 | 40.68B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.69 | 33.06B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.16 | 31.30B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
208.10 | 30.18B | 5.54B | 1.52B | 1.74B | 10.37 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-16-19 | Initiated | Ascendiant Capital Markets | Buy |
Daxor Corporation Stock (DXR) Latest News
Daxor Corporation (DXR) Holds Steady at $10.82 as Shares Test Key Support ZoneOpen Trading Community - Newser
DXR Q3 2007 Earnings: Significant Earnings Beat Driven by Strong Operational PerformanceEarnings Sentiment Score - Newser
Daxor Corporation (DXR) Q3 2007 Earnings: Landmark EPS Beat Lifts Sentiment Despite No Revenue DisclosureSocial Signal Watchlist - Newser
Number of shareholders of Daxor Corporation – FWB:DX5 - TradingView
DXR Daxor Q3 results shatter estimates with 3257 EPS surprise 3835 revenue surge driving 3 stock gainCommunity Sell Signals - Newser
How (DXR) Movements Inform Risk Allocation Models - Stock Traders Daily
TradingKey - TradingKey
Daxor (DXR) reports quarterly earnings as company outlines strategic priorities amid market uncertainty.Social Signal Watchlist - Newser
The long term thesis for Daxor (DXR) in plain sight (-4.73%) 2026-05-08Diagonal Spread Trade - Newser
Trading Systems Reacting to (DXR) Volatility - Stock Traders Daily
What Daxor (DXR) is doing that could pay off big later (Climbs) 2026-05-05Investment Community Signals - newser.com
Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis - The Globe and Mail
5,061,267 Common Stock of Daxor Corporation are subject to a Lock-Up Agreement Ending on 27-APR-2026. - marketscreener.com
How Daxor Corporation (DXR) Affects Rotational Strategy Timing - Stock Traders Daily
(DXR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
RSI Check: What is the long term forecast for Daxor Corporation stockEarnings Miss & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
CEO Moves: Is Daxor Corporation stock risky to hold now2026 Drop Watch & Consistent Profit Trading Strategies - baoquankhu1.vn
Insider Buying: Michael Feldschuh Acquires Additional Shares of Daxor Corp (DXR) - GuruFocus
Daxor CEO Feldschuh buys $9,070 in shares By Investing.com - Investing.com South Africa
Daxor CEO Feldschuh buys $9,070 in shares - Investing.com
DAXOR (DXR) CEO Michael Feldschuh adds 1,000 shares in open-market buy - Stock Titan
Daxor launches blood volume testing program in Ohio By Investing.com - Investing.com South Africa
Daxor Corporation Expands Customer Footprint With New BVA Program At High-Volume Ohio Cardiology Center - marketscreener.com
Daxor launches blood volume testing program in Ohio - Investing.com
Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center - GlobeNewswire
Income Plays: Is Daxor Corporation vulnerable to short sellers2026 Reactions & Smart Money Movement Tracker - baoquankhu1.vn
Can Daxor (DXR) Stock Double in 2026 | Price at $9.16, Down 5.52%RSI Oversold Stocks - Newser
[N-CEN/A] DAXOR CORP SEC Filing - Stock Titan
Insider Buying: Robert Michel Acquires Shares of Daxor Corp (DXR) - GuruFocus
Michel, Daxor CFO, buys $9,900 in DXR stock - Investing.com
Michel, Daxor CFO, buys $9,900 in DXR stock By Investing.com - Investing.com India
DAXOR CORP (DXR) CFO adds 1,000 shares in open-market buy - Stock Titan
DXR PE Ratio & Valuation, Is DXR Overvalued - Intellectia AI
Setup Watch: Will Daxor Corporation stock go up in YEARNew Guidance & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Earnings Risk: What is the target price for Daxor Corporation stock2026 Biggest Moves & High Accuracy Trade Alerts - baoquankhu1.vn
Daxor's Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026 - Bitget
Daxor’s Blood Volume Analysis Metric Validated as Uniquely - GlobeNewswire
Daxor Corporation (NASDAQ:DXR) Short Interest Update - MarketBeat
Daxor (DXR) chief medical officer Jefferies acquires shares worth $0 - Investing.com
Daxor (DXR) chief medical officer Jefferies acquires shares worth $0 By Investing.com - Investing.com Australia
Daxor (DXR) CMO boosts stake with 5,941-share equity grant - Stock Titan
Macro Review: What is the long term forecast for Daxor Corporation stockEarnings Trend Report & Daily Price Action Insights - baoquankhu1.vn
Institution Moves: What is the earnings history of Daxor CorporationChart Signals & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Daxor Corporation to Showcase Next-Generation Portable - GlobeNewswire
Daxor to showcase next-gen portable BVA at ACC.26 session - TipRanks
Daxor (DXR) Showcases Innovative Blood Volume Analyzer at Major Cardiology Event - GuruFocus
Daxor Corporation Showcases Next-Generation Portable Blood Volume Analyzer At ACC.26 - marketscreener.com
Daxor Corporation Stock (DXR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):